The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity

The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity

ObjectiveThis study aims to investigate the relationship between metabolic dysfunction-associated fatty liver disease (MAFLD) and sex hormones and sex hormone-binding globulin (SHBG) in boys with obesity.MethodsRetrospective analysis of metabolic indicators and sex hormone levels in boys with obesit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Wang, Shuyi Yang, Suming Zhang, Ye Yang, Siqing Li, Meiyu Zhang, Xiaona Li, Hua Bai, Peiliang Luo, Yingdi Yuan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Endocrinology
Subjects:	childhood obesity metabolic dysfunction-associated fatty liver disease (MAFLD) non-alcoholic fatty liver disease (NAFLD) sex hormone-binding globulin (SHBG) testosterone
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1446049/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Causal association of sex hormone-related traits with Alzheimer’s disease: a multivariable and network Mendelian randomization analysis
by: Yan Zhang, et al.
Published: (2025-02-01)

Profile of Children With Non-alcoholic Fatty Liver Disease Referred to a Hospital in Iran
by: Amin Ghanbari, et al.
Published: (2024-12-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

Triglycerides mediate the relationships of per- and poly-fluoroalkyl substance (PFAS) exposure with nonalcoholic fatty liver disease (NAFLD) risk in US participants
by: Wenying Qiao, et al.
Published: (2025-01-01)

Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China
by: Yu L, et al.
Published: (2025-02-01)

The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
by: Valeria Michelle Fernández-Garibay, et al.
Published: (2025-01-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Mediterranean diet improves liver health but does not protect against azoxymethane-induced colon tumorigenesis compared to Western diet in A/J mice
by: Weimin Guo, et al.
Published: (2025-03-01)

The development of a food-group, tree classification method and its use in exploring dietary associations with metabolic dysfunction-associated Steatotic liver disease (MASLD) and other health-related outcomes in a UK population
by: Amina A. Alawadi, et al.
Published: (2025-03-01)

Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis
by: Tingting Kong, et al.
Published: (2023-10-01)

Genome-wide association study of the fatty liver index in the Taiwanese population reveals shared and population-specific genetic risk factors across ethnicities
by: Pei Pei Lau, et al.
Published: (2025-02-01)

FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
by: Muhammad Mazhar Azam, et al.
Published: (2024-12-01)

Role of plasma metabolome in mediating the effect of plasma lipidome on NAFLD: a Mendelian randomization study
by: Zhuyuan Zheng, et al.
Published: (2025-01-01)

Association between sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Kasra Pirahesh, et al.
Published: (2025-02-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01)

Associations between intake of different types of vegetables and metabolic dysfunction-associated fatty liver disease: a population-based study
by: Chong Liu, et al.
Published: (2025-01-01)

Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives
by: Siyuan Yang, et al.
Published: (2025-01-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric study
by: Kangjie li, et al.
Published: (2025-03-01)

Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study
by: Ximing Wang, et al.
Published: (2025-01-01)

Potential alternative and novel biomarkers for paediatric MAFLD: exploratory evidence from a Chinese cohort
by: Fan Yang, et al.
Published: (2025-01-01)

Dose-response relationship between the fatty liver index and asthma risk: NHANES 2001~2018
by: Tengfei Sun, et al.
Published: (2025-02-01)

Lymph Node Adiposity and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Jessica M. Rubino, et al.
Published: (2025-01-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Association between the composite dietary antioxidant index and non-alcoholic fatty liver disease: evidence from National Health and Nutrition Examination Survey 2005–2016
by: Yidian Fu, et al.
Published: (2025-01-01)

Association Between Sociodemographic Variables, Healthy Habits, and Stress with Risk Scales for Liver Disease Associated with Metabolic Dysfunction
by: Ángel Arturo López-González, et al.
Published: (2025-01-01)

Pre-diabetes and cardiovascular risk factors in NAFLD patients: a retrospective comparative analysis
by: Azam Teimouri, et al.
Published: (2025-02-01)

The Role of the Liver in the Pathophysiology of PCOS: A Literature Review
by: Abrar Alhermi, et al.
Published: (2025-01-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)

Effects of laparoscopic sleeve gastrectomy on nonalcoholic fatty liver disease and TGF-β signaling pathway
by: Hideki Kumagai, et al.
Published: (2024-02-01)

Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review
by: Hongcai Li, et al.
Published: (2025-02-01)

Platelet‐derived apoptotic vesicles ameliorate nonalcoholic fatty liver disease by regulating lipid metabolism via apolipoprotein A‐II
by: Yuhe Jiang, et al.
Published: (2025-01-01)

Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model
by: Sebastian Holländer, et al.
Published: (2025-01-01)

High-starchy carbohydrate diet aggravates NAFLD by increasing fatty acids influx mediated by NOX2
by: Yuqi Gao, et al.
Published: (2023-07-01)

The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
by: Hongsheng Li, et al.
Published: (2025-03-01)

Sex differences in the neuroinflammatory signaling pathway: effect of miRNAs on fatty acid synthesis in microglia
by: Haolin Zheng, et al.
Published: (2025-02-01)

Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)
by: Zobair M. Younossi, et al.
Published: (2025-03-01)